Investor Dossier
Capital Cell
active
Typeinvestor
Location—
Portfolio (7 investments)
EVerZom
Series A · Oct 2025
€10.0M
Axoltis Pharma
Series A · Dec 2025
€18.0M
Kervalion
Seed · Mar 2026
LEAD
€700K
Apmonia Therapeutics
Series A · Jan 2026
€10.0M
Yomi Pharma
Other · Oct 2025
LEAD
€1.2M
Hemerion Therapeutics
Series A · Jun 2025
LEAD
€6.5M
MSInsight
Seed · Mar 2025
€1.6M